Hospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial

    BJU International, Vol. 125, Núm. 2, pp. 215-225